PODXL and neoplasm: We demonstrated the inability of PDx inhibition to reverse MDA-MB-231-mediated macrophage suppression in these settings, which suggests a potential tumour immune evasion strategy and underscores the need for novel therapeutic strategies aiming to modulate macrophage polarisation states.